MeOmics Technology
MeOmics is a pioneering company in psychiatric drug discovery, leveraging an AI-enhanced human neuronal cell platform to deliver patient-specific insights and improve treatment outcomes. By integrating stem cell biology, electrophysiology, and machine learning, they create predictive biomarkers to stratify patients early in drug development, bringing precision medicine to psychiatry. The company addresses the high failure rates and lack of translatable models in psychiatric research by using patient-derived iPSC neurons and multi-electrode array technology, analyzed with proprietary AI, to identify distinct patient groups and uncover patterns related to symptoms and drug response. They collaborate with leading mental healthcare institutions, using real-world patient data to validate their platform, which has already stratified neuronal phenotypes from individuals with psychosis. MeOmics offers partnerships to biotech and pharma companies looking to de-risk preclinical discovery and clinical entry.
MeOmics Technology
MeOmics is a pioneering company in psychiatric drug discovery, leveraging an AI-enhanced human neuronal cell platform to deliver patient-specific insights and improve treatment outcomes. By integrating stem cell biology, electrophysiology, and machine learning, they create predictive biomarkers to stratify patients early in drug development, bringing precision medicine to psychiatry. The company addresses the high failure rates and lack of translatable models in psychiatric research by using patient-derived iPSC neurons and multi-electrode array technology, analyzed with proprietary AI, to identify distinct patient groups and uncover patterns related to symptoms and drug response. They collaborate with leading mental healthcare institutions, using real-world patient data to validate their platform, which has already stratified neuronal phenotypes from individuals with psychosis. MeOmics offers partnerships to biotech and pharma companies looking to de-risk preclinical discovery and clinical entry.